Visão geral da empresa ProSciento
2 escritóriosLocalizações
Connecting clients, partners and patients to develop new treatments for diabetes and related metabolic diseases.
We are proud to be a leading scientific voice and contributor to advancements in new therapeutics and devices for metabolic diseases. As a full-service clinical research organization (CRO), we work with clients of all sizes worldwide to design and conduct multinational clinical trials, from clinical development and regulatory planning for new investigational drugs through phase 2b and including augmentation of phase 3 clinical trials.
Our team of science-driven experts is widely recognized for our contributions to research and therapeutic development for diabetes, NASH, and obesity. Our leadership in metabolic disease research is reflected in our deep connections with clients and partners and our commitment to advancing science and achieving quality results.
For more information, please visit www.prosciento.com
Our team of science-driven experts is widely recognized for our contributions to research and therapeutic development for diabetes, NASH, and obesity. Our leadership in metabolic disease research is reflected in our deep connections with clients and partners and our commitment to advancing science and achieving quality results.
For more information, please visit www.prosciento.com
